Board of Directors

克里斯托弗·b·贝格利

Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Executive Chairman and Chief Executive Officer, Hospira, Inc.

克里斯托弗·b·贝格利

Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Executive Chairman and Chief Executive Officer, Hospira, Inc.

导演Since 2012 ; Lead Independent Director 2021-2023; Chairman Since 2023

Executive Chairman of the Board of Hospira, Inc. from May 2007 until his retirement in January 2012. Mr. Begley also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division. He earned a bachelor’s degree from Western Illinois University and an MBA from Northern Illinois University.
Other Public Board Memberships

过去的导演和吊架的非执行董事长, Inc. (until October 2022)
Past director and Non-Executive Chairman of Adtalem Global Education Inc. (formerly known as DeVry Education Group Inc.) (until November 2017)

Other Relevant Experience

Past director of the Advanced Medical Technology Association (“AdvaMed”), the medical device industry’s trade association

Member of theCorporate Governance Committee
Member of theQuality, Regulatory and Technology Committee

Betsy J. Bernard

Retired President, AT&T Corp.

Betsy J. Bernard

Retired President, AT&T Corp.

自2009年以来,导演

President of AT&T Corp. from October 2002 until her retirement in December 2003. From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer. Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell. Ms. Bernard received a B.A. degree from St. Lawrence University, an MBA from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program.

Other Public Board Memberships

Past director of Principal Financial Group, Inc. (until June 2020)
Past director of SITO Mobile Ltd. (until June 2017)

Member of theAudit Committee

Chair of theCorporate Governance Committee

Michael J. Farrell

Chief Executive Officer, ResMed Inc.

Michael J. Farrell

Chief Executive Officer, ResMed Inc.

导演Since 2014

Chief Executive Officer of ResMed Inc. since March 2013. Prior to that appointment, Mr. Farrell served as President – Americas for ResMed from 2011 to 2013. He was previously Senior Vice President of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development. Before joining ResMed in September 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company and BHP Billiton. Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology and an MBA from the MIT Sloan School of Management.

Other Public Board Memberships

ResMed Inc.

Other Relevant Experience

导演of AdvaMed

Chair of theCompensation and Management Development Committee

Member of theQuality, Regulatory and Technology Committee

Robert A. Hagemann

Retired Senior Vice President and Chief Financial Officer, Quest Diagnostics Incorporated

Robert A. Hagemann

Retired Senior Vice President and Chief Financial Officer, Quest Diagnostics Incorporated

导演Since 2008

高级副总裁兼首席财务官of Quest Diagnostics Incorporated until his retirement in July 2013. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998. Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

Other Public Board Memberships

Graphic Packaging Holding Company
Ryder System, Inc.

Chair of theAudit Committee

Member of theCorporate Governance Committee

Ivan Tornos

导演, President and Chief Executive Officer, Zimmer Biomet Holdings, Inc.

Ivan Tornos

导演, President and Chief Executive Officer, Zimmer Biomet Holdings, Inc.

导演Since 2023

Ivan Tornos was appointed President and Chief Executive Officer and a member of the Board of Directors of Zimmer Biomet in August 2023.

Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. He was appointed as Chief Operating Officer in March 2021 with responsibility for overseeing all global businesses at Zimmer Biomet, as well as leading the global operations, clinical and medical education and global R&D and New Product Development functions. In this role, he had oversight of the Americas and the Europe, Middle East and Africa (EMEA) regions.

Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. Before joining C.R. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Before that, Mr. Tornos served as International Vice President, Business Development and Strategy with Baxter International Inc. and prior to that, he spent over a decade in leadership assignments around the globe with Johnson & Johnson. Mr. Tornos currently serves as an independent member of the Board of Directors of global healthcare company PHC Holdings Corporation.

Mr. Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program and also completed leadership and management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business.

Arthur J. Higgins

Operating Advisor to the Abu Dhabi Investment Authority

Arthur J. Higgins

Operating Advisor to the Abu Dhabi Investment Authority

导演Since 2007

Operating Advisor to the Abu Dhabi Investment Authority since June 2021, and Deputy Chairman of the Board of UNION therapeutics A/S since July 2021. Previously, Consultant, Blackstone Healthcare Partners of The Blackstone Group from June 2010 until June 2021. Mr. Higgins served as Non-Executive Chairman of the Board of Assertio Holdings, Inc., successor issuer to Assertio Therapeutics, Inc., from May 2020 until December 2020. Prior to that, he served as President and Chief Executive Officer and a member of the board of directors of Assertio Therapeutics, Inc. from March 2017 until its merger with Zyla Life Sciences in May 2020. Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Other Public Board Memberships

Ecolab Inc.
Past director of Assertio Holdings, Inc. (until December 2020)
Past director of Assertio Therapeutics, Inc. (until May 2020)
Past director of Endo International plc (until March 2017)

Member of theCompensation and Management Development Committee

Member of theQuality, Regulatory and Technology Committee

Maria Teresa Hilado

Retired Executive Vice President and Chief Financial Officer, Allergan plc

Maria Teresa Hilado

Retired Executive Vice President and Chief Financial Officer, Allergan plc

导演Since 2018

Executive Vice President and Chief Financial Officer of Allergan plc, a global pharmaceutical company, from December 2014 until her retirement in February 2018. Prior to joining Allergan, Ms. Hilado served as Senior Vice President, Finance and Treasurer of PepsiCo Inc. from 2009 until 2014. She previously served as Vice President and Treasurer for Schering-Plough Corp. from 2008 to 2009 and spent more than 17 years with General Motors Co. in leadership roles of increasing responsibility, including Assistant Treasurer from 2006 to 2008 and Chief Financial Officer, GMAC Commercial Finance LLC from 2001 to 2005. She began her career with Far East Bank and Trust Co. in Manila, Philippines. Ms. Hilado earned a Bachelor’s degree in Management Engineering from Ateneo de Manila University in the Philippines and an MBA from the University of Virginia Darden School of Business.

Other Public Board Memberships

Campbell Soup Company
Past director of H.B. Fuller Company (until December 2021)
Past director of PPD, Inc. (until December 2021)

Member of the Audit Committee
Member of the Corporate Governance Committee

Syed Jafry

退休的高级副总裁和主席区ns, Thermo Fisher Scientific, Inc.

Syed Jafry

退休的高级副总裁和主席区ns, Thermo Fisher Scientific, Inc.

导演Since 2018

退休的高级副总裁和主席区ns, of Thermo Fisher Scientific, Inc. from September 2017 through his retirement in March 2022. Mr. Jafry is responsible for all business geographies outside the U.S. He joined Thermo Fisher Scientific in March 2005 and served in numerous roles of increasing responsibility prior to being appointed to his current position. Mr. Jafry started his career at Glaxo Pharmaceuticals in London. Prior to joining Thermo Fisher Scientific, he served for 18 years at General Electric, where he held commercial, product management and general management roles in the U.S., Netherlands, Switzerland and China, most recently serving as President of GE Sensing Asia. Mr. Jafry holds a Master’s degree in Mechanical Engineering from the University of Massachusetts, a Master’s certificate in Marketing and Management from Harvard University Extension School and a Bachelor’s degree in Mechanical Engineering from Lahore University in Pakistan.

Member of the Compensation and Management Development Committee
Member of the Quality, Regulatory and Technology Committee

Sreelakshmi Kolli

Executive Vice President, Chief Digital Officer, Align Technology, Inc.

Sreelakshmi Kolli

Executive Vice President, Chief Digital Officer, Align Technology, Inc.

导演since 2021

Executive Vice President, Chief Digital Officer of Align Technology, Inc., a global medical device company (“Align”), since February 2022. Ms. Kolli is responsible for leading software, data, enterprise, cloud and infrastructure engineering teams focused on design and development of digital products and services. This includes defining the technology strategy and development of product software, consumer, customer, manufacturing and enterprise applications enabling the Align Digital Platform. In addition, she led Align’s global business transformation initiative aimed at delivering platforms and technology to support customer experience and simplified business processes across the company. She joined Align in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure. She was promoted to Vice President, Information Technology in December 2012, to Senior Vice President, Global Information Technology in February 2018 and to Senior Vice President, Chief Digital Officer in April 2020. Prior to joining Align, Ms. Kolli held technical lead positions with Citadon and Accenture. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco. Ms. Kolli earned an M.S. degree in Computer Applications at the National Institute of Technology in Trichy, India and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.

Member of theAudit Committee

Chair of theQuality, Regulatory and Technology Committee

Michael W. Michelson

Retired Senior Advisory Partner, KKR Management LLC, the general partner of KKR & Co. L.P.

Michael W. Michelson

Retired Senior Advisory Partner, KKR Management LLC, the general partner of KKR & Co. L.P.

导演Since 2015

Senior Advisory Partner, KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P., from January 2018 until his retirement in January 2020. Previously, Member, KKR Management LLC since October 2009. Before that, Mr. Michelson was a member of the limited liability company that served as the general partner of Kohlberg Kravis Roberts & Co. L.P. since 1996. He joined KKR in 1981. Mr. Michelson has played a significant role in the development of KKR’s portfolio companies. He began his professional career with the law firm of Latham & Watkins in Los Angeles, where he was involved in a broad corporate practice while specializing in management buyouts. He earned an A.B. from Harvard College and a J.D. from Harvard Law School.

Other Public Board Memberships

HCA Healthcare, Inc.

Other Relevant Experience

Served as a director of Biomet prior to the merger of Zimmer and Biomet

Member of theCompensation and Management Development Committee

Member of theQuality, Regulatory and Technology Committee

ZIMMER BIOMET

345 East Main Street, Warsaw IN 46580

1.800.613.6131

Delivered by Investis – link to website (opens in a new window)